AgNovos Healthcare spine device achieves FDA breakthrough designation

The FDA awarded AgNovos Healthcare’s AGN1 Local Osteo-enhancement Procedure small volume kit breakthrough device designation on March 26.

Advertisement

Three insights:

1. The AGN1 LOEP SV kit is an investigational device designed to treat stable vertebral compression fractures.

2. The kit features a tri-phasic implant material that is designed to couple the pace of resorption to bone formation so treated vertebrae are protected.

3. The tri-phasic implant material is approved in Europe to treat bone loss in higher volume applications at other anatomical sites.

More articles on devices:
6 industry layoffs, furloughs for physician leaders to know
Dr. Neal ElAttrache defends orthopedic surgeries performed during COVID-19 crisis
‘The patients are deferred; they’re not going away,’ says Life Spine CEO on coronavirus

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.